{"id":101319,"date":"2021-03-30T10:09:53","date_gmt":"2021-03-30T08:09:53","guid":{"rendered":"https:\/\/rtvnp.rs\/?p=101319"},"modified":"2021-03-30T10:09:53","modified_gmt":"2021-03-30T08:09:53","slug":"fajzerova-vakcina-odobrena-za-upotrebu-u-bih","status":"publish","type":"post","link":"https:\/\/arhiva.rtvnp.rs\/?p=101319","title":{"rendered":"Fajzerova vakcina odobrena za upotrebu u BiH"},"content":{"rendered":"<p>Agencija za lekove BiH odobrila je upotrebu vakcine kompanija Fajzer i Bajontek u BiH, javlja Klix.ba.<\/p>\n<p>Kako navodi sarajevski portal, po\u0161iljka ovih vakcina je pro\u0161le sedmice stigla u Sarajevo.<\/p>\n<p>Kontingent od 23.400 doza Fajzerovih vakcina je do\u0161ao putem Kovaks mehanizma, a nakon izvr\u0161enog pregleda dokumentacije, Kontrolna laboratorija Agencije za lekove je danas odobrila upotrebu u BiH.<\/p>\n<p>Kada je re\u010d o vakcinama kompanije AstraZeneka, \u010deka se kompletna dokumentacija kako bi Agencija za lekove zapo\u010dela proces odobravanja.<\/p>\n<p>Preko Kovaks mehanizma u BiH je pro\u0161le sedmice stiglo 26.400 doza vakcine Astrazeneka.<\/p>\n<p>Za kineske vakcine koje su u nedelju stigle kao donacija Turske jo\u0161 nije podnet zahtev za odobravanje.<\/p>\n<p>&nbsp;<\/p>\n<p>Izvor: Tanjug<\/p>\n<p>Foto: N1<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Agencija za lekove BiH odobrila je upotrebu vakcine kompanija Fajzer i Bajontek u BiH, javlja Klix.ba. Kako navodi sarajevski portal, po\u0161iljka ovih vakcina je pro\u0161le sedmice stigla u Sarajevo. Kontingent od 23.400 doza Fajzerovih vakcina je do\u0161ao putem Kovaks mehanizma, a nakon izvr\u0161enog pregleda dokumentacije, Kontrolna laboratorija Agencije za lekove je danas odobrila upotrebu u [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":101320,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[75],"tags":[],"class_list":["post-101319","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-region"],"_links":{"self":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/posts\/101319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=101319"}],"version-history":[{"count":0,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/posts\/101319\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=\/wp\/v2\/media\/101320"}],"wp:attachment":[{"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=101319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=101319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arhiva.rtvnp.rs\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=101319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}